Back to top
more

Zoetis (ZTS)

(Delayed Data from NYSE)

$170.37 USD

170.37
5,361,644

-4.90 (-2.80%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $170.37 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (92 out of 251)

Industry: Medical - Drugs

Zacks News

Sweta Killa headshot

5 Top-Ranked Stocks That Powered S&P 500 Rally

We have highlighted five top-ranked stocks that have led the S&P 500's five-year run from 2,000 to 3,000.

Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here is Why Growth Investors Should Buy Zoetis (ZTS) Now

Zoetis (ZTS) could produce exceptional returns because of its solid growth attributes.

JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

Zoetis (ZTS) Down 0.8% Since Last Earnings Report: Can It Rebound?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss

Zoetis???s (ZTS) earnings beat estimates but sales miss the same in the first quarter of 2019.

JAZZ vs. ZTS: Which Stock Should Value Investors Buy Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

Zoetis (ZTS) Tops Q1 Earnings Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 11.39% and -0.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

Zoetis (ZTS) is expected to provide updates on the pipeline, when it reports first-quarter 2019 results on May 2.

Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run?

Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis

Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis

4 GARP Stocks to Scoop Up for Maximum Returns

If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

Why Is Zoetis (ZTS) Up 3.9% Since Last Earnings Report?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zoetis (ZTS) Beats on Q4 Earnings & Sales, Shares Up

Zoetis (ZTS) exceeds both earnings and sales expectations in the fourth quarter of 2018.

Zoetis (ZTS) Tops Q4 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 2.60% and 3.14%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?

Zoetis Inc. (ZTS) is gearing up to report fourth-quarter 2018 results. The company continues to strengthen its diverse product portfolio through lifecycle innovations, strong customer relationships, and access to new markets and technologies.

Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake

Eli Lilly (LLY) to initiate an exchange offer for shareholders to divest its remaining ownership interest in Elanco

Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Zoetis (ZTS) Stock Outpacing Its Medical Peers This Year?

Is (ZTS) Outperforming Other Medical Stocks This Year?

Zoetis Sees Hammer Chart Pattern: Time to Buy?

Zoetis has been struggling lately, but the selling pressure may be coming to an end soon.

Zoetis (ZTS) Down 0.4% Since Last Earnings Report: Can It Rebound?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Is Zoetis (ZTS) Outperforming Other Medical Stocks This Year?

Is (ZTS) Outperforming Other Medical Stocks This Year?

Can Zoetis (ZTS) Stock Continue to Grow Earnings?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Zoetis (ZTS).